Article
P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cells
2017-07-26
Abstract excerpt
<h4>SUMMARY</h4> CRISPR/Cas9 has revolutionized our ability to engineer genomes and to conduct genome-wide screens in human cells. While some cell types are easily modified with Cas9, human pluripotent stem cells (hPSCs) poorly tolerate Cas9 and are difficult to engineer. Using a stable Cas9 cell line or transient delivery of ribonucleoproteins (RNPs) we achieved an average insertion or deletion efficiency greate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e3d4af30-66fa-50c7-893b-62d7943b683e
- DOI
- 10.1101/168443
